Back to Search

ANH MAI, M.D.

M.D.

Pediatrics Physician

NPI: 1871913848IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

310101(LA)
Pediatrics PhysicianPrimary

Pediatrics

Code: 208000000X

310101(LA)

CMS Specialties

PrimaryINTERNAL MEDICINE

Education

UNIVERSITY OF MISSOURI, KANSAS CITY, SCHOOL OF MEDICINE

Class of 2013

Research & Publications (20)

Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors.
PMID 19663498·J Med Chem·2009
7-preclinical
epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors.
PMID 18348515·J Med Chem·2008
8-other
Synthesis and biological properties of novel 2-aminopyrimidin-4(3H)-ones highly potent against HIV-1 mutant strains.
PMID 17910429·J Med Chem·2007
8-other
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemia.
PMID 17666592·Mol Pharmacol·2007
8-other
The therapeutic uses of chromatin-modifying agents.
PMID 17504020·Expert Opin Ther Targets·2007
6-review
Novel pyrrole-containing histone deacetylase inhibitors endowed with cytodifferentiation activity.
PMID 17482499·Int J Biochem Cell Biol·2007
8-other
Synthesis and biological validation of novel synthetic histone/protein methyltransferase inhibitors.
PMID 17458842·ChemMedChem·2007
4-observational
Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
PMID 17196388·Bioorg Med Chem Lett·2007
8-other
Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties.
PMID 17154519·J Med Chem·2006
8-other
Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors.
PMID 17004718·J Med Chem·2006
7-preclinical
Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition.
PMID 16892355·ChemMedChem·2006
8-other
Synthesis and biological evaluation of 2-, 3-, and 4-acylaminocinnamyl-N-hydroxyamides as novel synthetic HDAC inhibitors.
PMID 16787320·Med Chem·2005
8-other
3-(1H-pyrrol-2-yl)-2-oxazolidinones as novel monoamine oxidase type A inhibitors.
PMID 16787307·Med Chem·2005
7-preclinical
Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors.
PMID 16302818·J Med Chem·2005
8-other
Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates.
PMID 16165353·Bioorg Med Chem Lett·2005
7-preclinical
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides.
PMID 15857140·J Med Chem·2005
8-other
5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family.
PMID 15727860·Bioorg Med Chem·2005
8-other
Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
PMID 15717297·Med Res Rev·2005
6-review
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity.
PMID 14971890·J Med Chem·2004
7-preclinical
Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A.
PMID 14584932·J Med Chem·2003
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
200 BROADWAY ST STE 230
NEW ORLEANS, LA 70118

Locations (2)

Practice Location

200 BROADWAY ST STE 230, NEW ORLEANS, LA
(504) 988-9000

Practice Location

275 LASALLE ST, NEW ORLEANS, LA
(504) 988-5030

Quick Facts

NPI
1871913848
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
13
Publications
20

Are you this provider?

Claim Your Profile